News & Updates

The use of nasal spray zavegepant 10 mg provides freedom from pain and the most bothersome migraine symptom (MBS*) at 2 hours after treatment in women with acute migraine, according to the pooled analysis of the two trials presented at AAN 2024.

Treatment with the investigational agent AXS-07 significantly alleviates pain and most bothersome symptoms (MBS) in patients with migraine, according to results of a pooled analysis of the phase III MOMENTUM and INTERCEPT trials presented at AAN 2024.

A prospective cohort study has shown that dementia is more common in individuals with essential tremor than in the general population, highlighting the need to identify those at risk early.

People with sleep apnoea tend to also show memory or cognitive symptoms, according to a study, suggesting an association between the sleep-related breathing disorder and cognitive function.

Application of the modified Alpha stent, an intracranial closed-cell stent with a unique mesh design, delivers satisfactory outcomes in coil embolization of unruptured distal internal carotid artery (ICA) aneurysms, reports a study. Its recent adjustment facilitates a less complicated delivery and deployment.

Epilepsy surgery may hold promise for carefully selected patients past the age of 50 years, according to a study.

For patients with multiple sclerosis (MS) who are receiving treatment with natalizumab, getting shots with inactivated vaccines is safe and immunogenic, with the positive results persisting regardless of the duration of natalizumab therapy, as shown in a study.